🇰🇷 South Korea Country × Condition
atrial fibrillation af Clinical Trials in South Korea
Active clinical trials for atrial fibrillation af with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT07447297
Recruiting
Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation
Enrollment
520 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT07436299
Recruiting
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
Enrollment
400 pts
Country
🇰🇷 South Korea
Oslo University Hospital
View Trial → NCT07753200 Phase 4
Recruiting
Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
Enrollment
3,000 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → Frequently Asked Questions
How many atrial fibrillation af clinical trials are active in South Korea?
There are currently 3 active clinical trials for atrial fibrillation af with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a atrial fibrillation af clinical trial in South Korea?
To join a atrial fibrillation af clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atrial fibrillation af trials in South Korea?
Active atrial fibrillation af trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology